The dyslipidemic effect of cytostatics in the treatment of early breast cancer as a serious risk factor of cardiovascular diseases [0.03%]
细胞毒性药物治疗早期乳腺癌的血脂紊乱效应作为一个严重的心血管疾病危险因素
L Rušinová,M Kozárová,Z Kozelová et al.
L Rušinová et al.
Backround: The development of highly effective anti-cancer therapies over the past several decades has dramatically changed the situation of patients with malignant tumor disease, who currently achieve a high rate of cure...
Treatment of tobacco dependence in cancer patients - Recommendations of the Section of Supportive Treatment and Care and the Section of Preventive Oncology of the Czech Cancer Society of the Czech Medical Association of J. E. Purkyně, Working Group for t… [0.03%]
癌症患者烟草依赖的治疗-捷克抗癌协会捷克耶·恩斯特·普尔凯尼医学协会支持治疗和护理部门和预防肿瘤学工作组的意见书摘要
K Zvolská,E Králíková,S Vokurka et al.
K Zvolská et al.
Smoking is a significant risk factor for the development of many cancers. In addition, after a cancer dia-gnosis, it also has an adverse effect on survival, the course and effectiveness of cancer treatment and quality of life, and increases...
Immunohistochemical analysis of CD9, CD29 and epithelial to mesenchymal transition in triple-negative breast cancer [0.03%]
三阴性乳腺癌CD9、CD29的免疫组化分析及上皮间质转化研究
R- Ondruššek,S Brychtová,M Bezděková et al.
R- Ondruššek et al.
Background: Triple-negative breast carcinomas (TNBC) are a heterogeneous group of tumors with mostly aggressive behaviour and poor prognosis. In association with their aggressive behavior and chemoresistance to treatment,...
Analysis of the effect of baseline detection and early clearance of ct-DNA, on survival outcomes among patients with advanced EGFR-mutant non-small cell lung cancer [0.03%]
基线ctDNA检测和早期转阴对EGFR突变晚期非小细胞肺癌患者生存获益的影响分析
A Joel,R Abarna,R T Chacko et al.
A Joel et al.
Background: To determine if circulating tumor DNA (ct-DNA) dynamics of epidermal growth factor receptor (EGFR) mutation in plasma can identify a subset of patients with EGFR-mutant (EGFR- m) non-small cell lung cancer (NS...
Evaluation pattern within tumor microenvironment and consequent gene expression in oral cancer [0.03%]
肿瘤微环境内的评估模式及其对口腔癌基因表达的影响
A Vasheghani Farahani,M Kavousi,F Jamshidian
A Vasheghani Farahani
Background: Oral squamous cell carcinoma (OSCC) is one of the most common cancers in the head and neck squamous cell cancer group. The increasing frequency of oral carcinomas and their late-stage appearance is a major wor...
D Nižňanská,M Vlachová,J Gregorová et al.
D Nižňanská et al.
Background: Multiple myeloma (MM) is a heterogeneous hematological malignancy characterized by clonal expansion of malignant plasma cells in the bone marrow. The disease is accompanied by various clinical manifestations, ...
M Eid,Arnošt Martínek,Jiří Dolina et al.
M Eid et al.
Background: The incidence of pancreatic cancer (pancreatic ductal adenocarcinoma - PDAC) is increasing, especially in developed countries. In 2021, 496,000 new PDAC cases were dia-gnosed worldwide. In the Czech Republic, ...
M Domanský,J Kubeš
M Domanský
Background: Cardiovascular diseases represent the most common non-oncologic cause of death in patients following radiotherapy (RT) in the thoracic region. Radiation-induced heart disease (RIHD) can manifest as various het...
The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 (4.2024) [0.03%]
遗传性乳腺癌、卵巢癌、前列腺癌和胰腺癌易感基因BRCA1、BRCA2、PALB2、ATM和CHEK2携带者的临床实践指南（2024版）
P Kleiblová,J Novotný,D Cibula et al.
P Kleiblová et al.
The Guidelines for Clinical Practice for carriers of pathogenic variants in clinically relevant cancer predisposition genes define the steps of primary and secondary prevention that should be provided to these individuals at high risk of de...
Advanced gastric cancer with peritoneal oligometastases treated with adaptive radiotherapy and concurrent chemotherapy [0.03%]
适应性放疗联合同步化疗治疗腹膜寡转移的晚期胃癌患者
Y Hama,E Tate
Y Hama
Background: There are no reports of concurrent chemoradiotherapy for gastric cancer with peritoneal oligometastases. Case description: ...